Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Retroviral vectors.

S H Kim1, S Kim, P D Robbins

  • 1Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pennsylvania, USA.

Advances in Virus Research
|October 29, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exosomes in the Pathogenesis, Diagnosis and Treatment of Pancreatic Diseases.

CellR4-- repair, replacement, regeneration, & reprogramming·2021
Same author

Age-dependent changes in intervertebral disc cell mitochondria and bioenergetics.

European cells & materials·2018
Same author

Exosomes as biomarkers and therapeutic tools for type 1 diabetes mellitus.

European review for medical and pharmacological sciences·2017
Same author

Possibilities of gene therapy in traumatic and degenerative lesions of the joints. Current experimental status and preliminary clinical applications.

Der Orthopade·2017
Same author

NF-κB inhibition reveals a novel role for HGF during skeletal muscle repair.

Cell death & disease·2015
Same author

Renal cell carcinoma to haemangioblastoma metastasis: a rare manifestation of Von Hippel-Lindau syndrome.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2014
Same journal

Transcriptional regulation of human endogenous retroviruses in cancer.

Advances in virus research·2026
Same journal

Viral threats to pregnancy: Global health risks in the era of pandemics.

Advances in virus research·2026
Same journal

Transforming crop protection: The role of RNAi in mitigating barley yellow dwarf virus and aphid infestation in cereal crops.

Advances in virus research·2025
Same journal

Vertical transmission of tomato viruses.

Advances in virus research·2025
Same journal

Consequences of seed transmission for plant virus emergence.

Advances in virus research·2025
Same journal

The significance of studying high-consequence pathogens in their natural reservoirs.

Advances in virus research·2025
See all related articles

Retroviral vectors stably modify cells for gene therapy without hindering growth. Advances enable their use in vivo for treating diseases like cancer and HIV, expanding gene therapy applications.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Gene Therapy

Background:

  • Retroviral vectors are crucial tools in preclinical and clinical gene therapy.
  • They offer stable genetic modification without impacting cell proliferation.
  • Murine retrovirus-based vectors are particularly effective for ex vivo applications involving rapidly dividing cells.

Purpose of the Study:

  • To review the applications and advancements of retroviral vectors in gene therapy.
  • To highlight the transition of retroviral vector use from ex vivo to in vivo strategies.
  • To discuss the future potential of retroviral vectors in treating genetic and acquired diseases.

Main Methods:

  • Review of existing literature on retroviral vector applications.
  • Analysis of preclinical and clinical studies utilizing retroviral vectors.

Related Experiment Videos

  • Examination of recent technological advancements in retroviral vector production and targeting.

    • Main Results:

    • Retroviral vectors have been successfully employed in ex vivo gene therapy for genetic disorders (e.g., Gaucher, SCID) and acquired diseases (e.g., cancer, arthritis).
    • Recent production advancements have enabled in vivo applications for conditions including cancer and human immunodeficiency virus (HIV).
    • Targeting capabilities are enhancing the utility of high-titer retroviral vectors for in vivo gene therapy.

    Conclusions:

    • Retroviral vectors are versatile and effective tools for both preclinical and clinical gene therapy.
    • Their utility is expanding with advancements enabling in vivo applications.
    • Retroviral vectors are expected to remain integral to future ex vivo and in vivo gene therapy strategies.